Navigation Links
For Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabThera's Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent
Date:8/30/2010

BURLINGTON, Mass., Aug. 30 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, 41 percent of surveyed European hematologist-oncologists say that the favorable efficacy profile of Roche's MabThera (rituximab) is the most significant driver of their use of this brand, while 26 percent say MabThera's favorable risk-benefit profile is the most significant driver.

The new European Physician & Payer Forum report entitled Will Emerging MAbs Threaten MabThera's Domination of the Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia Markets in Europe? Clinician and Payer Perspectives finds that sales of MabThera, which was first marketed more than a decade ago, continue to dwarf those of more recently launched monoclonal antibodies (MAbs) such as Genzyme's MabCampath and Bayer's Zevalin. When asked what safety/toxicity improvements over MabThera would carry the most weight in convincing prescribers to switch from MabThera to a novel MAb, the largest group of surveyed clinicians in France, Germany, Italy, Spain and the United Kingdom (EU5) cite concern about the rate of infections, although many are satisfied with the safety of MabThera.

"Thirty seven percent of surveyed European hematologist-oncologists say that an improvement in the rate of infections would carry the most weight, while 20 percent of surveyed clinicians cite concern about the rate of neutropenia," said Decision Resources Analyst Andrew Merron, Ph.D. "However, more than one-quarter of surveyed European hematologist-oncologists say that all side effects associated with MabThera are manageable."

The report also finds that emerging MAbs will not only face competition from MabThera in the EU5 markets but also from biosimilar rituximab. In the United Kingdom, interviewed payers expect that biosimilars will be
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank Pharmaceuticals, ... for the treatment of Hepatitis B virus (HBV) ... of a $22 million financing. Funds from this ... a novel, broad spectrum antiviral agent derived from ... hybrid (SMNH) chemistry platform, into Phase II clinical ...
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
(Date:2/26/2015)... 2015  CSSi, ( www.CSSiEnroll.com ) the leader ... industry, is pleased to announce the recent appointment ... Manager, adding significant value and expertise to our ... Karen is an accomplished, ... successfully lead the navigation of the program life ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Completes $22 Million Financing 2CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today ... for Medicinal Products for Human Use (CHMP) and ... 25th, following the,CHMP,s September meeting where CHMP considered ... for the,treatment of patients with non-metastatic, resectable osteosarcoma, ...
... Preventing Possibly Life-Threatening,Condition During Air Travel, ALEXANDRIA, ... (APTA) supports the recent "Call to Action" by,Acting ... reduce the number of,cases of deep vein thrombosis ... According to Susan Scherer, PT, PhD, associate professor ...
Cached Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3
(Date:2/27/2015)... The Radiology Business Management Association ... class of Fellows — one of the most highly ... , Since 2009, the RBMA Fellowship program has ... members to the Association and the profession. Fellow of ... Fellow candidate must meet a very high standard for ...
(Date:2/27/2015)... Leading massage chair retailer Emassagechair.com is known ... month they take a look at leading issues and help ... In the month of March they will be recognizing National ... by bringing awareness to the time change that occurs as ... start on March 2nd, and last until March 8th when ...
(Date:2/27/2015)... to a Feb. 12, 2015 news release by Verastem, ... by killing cancer stem cells, has received orphan drug designation ... in the treatment of mesothelioma.* According to the release, orphan ... development of drugs for the treatment of rare diseases. ... Melinda Helbock, Founder of The Law Office of Melinda J. ...
(Date:2/27/2015)... Atlanta, GA (PRWEB) February 27, 2015 ... firm, Martin Ventures, is collaborating with the Atlanta-based ... accelerate the adoption of Jvion’s advanced predictive capabilities ... predictive analytics company that identifies and prevents financial ... growing need for predictions that help prevent patient ...
(Date:2/27/2015)... Santa Cruz, CA (PRWEB) February 27, 2015 ... Opal Gas Processing Plant in Lincoln County, Wyoming. ... the area in preparation for interstate natural gas pipeline ... the natural gas., The Opal plant initially began operations ... expansions to serve growing natural gas production in Wyoming. ...
Breaking Medicine News(10 mins):Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2
... by the bird flu threat has resulted in poultry products ... capital. One can see that in Gazipur wholesale market chickens ... ,Only those chickens that were certified by the veterinary ... whereas those that were uncertified was available for a mere ...
... blood samples, taken from the people of Nandurbar district, is ... virus had spread to humans, even as the culling of ... ,Officials said the massive culling exercise in the region that ... to be completed by early Thursday. ,India's first ...
... ever-cervical cancer vaccine, Gardasil is expected to be launched ... 24 years of age. // Soon, men might also ... infecting their sexual partners and to protect themselves against ... under experimental phase, for demonstration of cervical cancer prevention. ...
... announced the approval of a new antifungal drug, for ... new drug called Eraxis, // is indicated in the ... ,The improved performance of Eraxis compared to ... have supported the approval. The drug can also be ...
... health problem of having too many ailing hearts, making it ... the bloc’s members, a whopping 169 billion euros in 2003, ... look at the annual statistics, but watch your heart before ... 230 euros on an average on Healthcare costs, per person. ...
... Inc. (OTCBB:MDLH) Needle– Free Injection System, designed specifically to ... toward establishing itself as a valuable instrument in the ... animals. With its patented ability to adjust pressure and ... the Company in a unique situation especially should there ...
Cached Medicine News:Health News:Delhi Sees Sharp Decline In Chicken Prices 2Health News:Delhi Sees Sharp Decline In Chicken Prices 3Health News:India Awaits Test Results To Confirm The Bird Flu Virus In Humans 2Health News:Men Might Get Their Share of Cervical Cancer Vaccine As Well 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 3
... difficile Panel is an enzyme immunoassay used ... antigen (glutamate dehydrogenase) and toxin A in ... as an aid in the diagnosis of ... of the Triage Microbiology product line, designed ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... CCD cameras provide fast, accurate, reliable and ... quality at an excellent price. , , ... TOMEY TR-4000 Auto Refractor provides highly accurate ... is obtained simply by pushing a button. ...
... SP-3000 covers all needs regarding pachymetry in ... care., ,Compact design, colored touch-screen and "quick ... an "easy-to-use unit.,The wide measurement range from ... the possibility to measure very thin or ...
Medicine Products: